Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M McIntyre

Showing results (801-810 of 870) with videos related to

Pageof 87
Sort By:
Allergy|August 7, 2016
Application of recombinant antigen 5 allergens from seven allergy-relevant Hymenoptera species in diagnosticsM Schiener, B Eberlein, C Moreno-Aguilar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 21, 2018
CD36 Enhances Vascular Smooth Muscle Cell Proliferation and Development of Neointimal HyperplasiaHong Yue, Maria Febbraio, Philip A Klenotic, et al.
Plos One|June 19, 2013
Plants know where it hurts: root and shoot jasmonic acid induction elicit differential responses in Brassica oleraceaTom O G Tytgat, Koen J F Verhoeven, Jeroen J Jansen, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 10, 2024
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified MedulloblastomaDon W Coulter, Yashpal S Chhonker, Devendra Kumar, et al.
Molecular Carcinogenesis|December 28, 2017
Suppression of STAT3 NH<sub>2</sub> -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21Sutapa Ray, Don W Coulter, Shawn D Gray, et al.
The Journal of Clinical Investigation|June 15, 1996
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseD M Stafforini, K Satoh, D L Atkinson, et al.
BMC Cancer|November 9, 2016
Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513Don W Coulter, Timothy R McGuire, John G Sharp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytesEdson F de Assis, Adriana R Silva, Lara F C Caiado, et al.
The Journal of Experimental Medicine|March 10, 2004
Lysophosphatidic acid induces neointima formation through PPARgamma activationChunxiang Zhang, Daniel L Baker, Satoshi Yasuda, et al.
The Journal of Biological Chemistry|March 30, 2001
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonistsS S Davies, A V Pontsler, G K Marathe, et al.
Pageof 87

Showing results (801-810 of 870) with videos related to

Sort By:
Pageof 87
Allergy|August 7, 2016
Application of recombinant antigen 5 allergens from seven allergy-relevant Hymenoptera species in diagnosticsM Schiener, B Eberlein, C Moreno-Aguilar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 21, 2018
CD36 Enhances Vascular Smooth Muscle Cell Proliferation and Development of Neointimal HyperplasiaHong Yue, Maria Febbraio, Philip A Klenotic, et al.
Plos One|June 19, 2013
Plants know where it hurts: root and shoot jasmonic acid induction elicit differential responses in Brassica oleraceaTom O G Tytgat, Koen J F Verhoeven, Jeroen J Jansen, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 10, 2024
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified MedulloblastomaDon W Coulter, Yashpal S Chhonker, Devendra Kumar, et al.
Molecular Carcinogenesis|December 28, 2017
Suppression of STAT3 NH<sub>2</sub> -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21Sutapa Ray, Don W Coulter, Shawn D Gray, et al.
The Journal of Clinical Investigation|June 15, 1996
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseD M Stafforini, K Satoh, D L Atkinson, et al.
BMC Cancer|November 9, 2016
Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513Don W Coulter, Timothy R McGuire, John G Sharp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytesEdson F de Assis, Adriana R Silva, Lara F C Caiado, et al.
The Journal of Experimental Medicine|March 10, 2004
Lysophosphatidic acid induces neointima formation through PPARgamma activationChunxiang Zhang, Daniel L Baker, Satoshi Yasuda, et al.
The Journal of Biological Chemistry|March 30, 2001
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonistsS S Davies, A V Pontsler, G K Marathe, et al.
Pageof 87